Meritage Portfolio Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
35,239
-1,200
| -3% | -$88.1K | 0.16% | 147 |
|
|
2025
Q1 | $4.16M | Buy |
36,439
+6,628
| +22% | +$757K | 0.28% | 108 |
|
|
2024
Q4 | $1.5M | Buy |
29,811
+2,783
| +10% | +$140K | 0.09% | 175 |
|
|
2024
Q3 | $1.25M | Buy |
27,028
+2,459
| +10% | +$114K | 0.08% | 189 |
|
|
2024
Q2 | $798K | Buy |
24,569
+119
| +0.5% | +$3.87K | 0.05% | 213 |
|
|
2024
Q1 | $616K | Sell |
24,450
-1,818
| -7% | -$45.8K | 0.04% | 228 |
|
|
2023
Q4 | $853K | Buy |
26,268
+949
| +4% | +$30.8K | 0.06% | 210 |
|
|
2023
Q3 | $690K | Buy |
25,319
+146
| +0.6% | +$3.98K | 0.05% | 214 |
|
|
2023
Q2 | $560K | Buy |
25,173
+5,585
| +29% | +$124K | 0.04% | 230 |
|
|
2023
Q1 | $424K | Sell |
19,588
-74
| -0.4% | -$1.6K | 0.03% | 223 |
|
|
2022
Q4 | $399K | Buy |
19,662
+607
| +3% | +$12.3K | 0.03% | 227 |
|
|
2022
Q3 | $489K | Buy |
19,055
+633
| +3% | +$16.2K | 0.04% | 212 |
|
|
2022
Q2 | $438K | Sell |
18,422
-456
| -2% | -$10.8K | 0.03% | 222 |
|
|
2022
Q1 | $425K | Buy |
18,878
+8,378
| +80% | +$189K | 0.03% | 231 |
|
|
2021
Q4 | $208K | Buy |
+10,500
| New | +$208K | 0.01% | 325 |
|